|
Page
|
|
|
Condensed Consolidated Interim Balance Sheets as of October 31, 2024 and July 31, 2024
|
3
|
|
Condensed Consolidated Interim Statements of Operations and Comprehensive Loss for the three months ended October 31, 2024 and 2023
|
4
|
|
Condensed Consolidated Interim Statements of Changes in Shareholders’ Deficiency for the three months ended October 31, 2024 and 2023
|
5
|
|
Condensed Consolidated Interim Statements of Cash Flows for the three months ended October 31, 2024 and 2023
|
6
|
|
Notes to the Condensed Consolidated Interim Financial Statements
|
7
|
|
DevvStream Holdings Inc.
|
|
CONDENSED CONSOLIDATED INTERIM BALANCE SHEETS
|
|
(Unaudited Expressed in United States dollars)
|
|
As at
|
October 31,
2024
|
July 31,
2024
|
||||||
|
ASSETS
|
||||||||
|
Current assets
|
||||||||
|
Cash
|
$
|
|
$
|
|
||||
|
GST receivable
|
|
|
||||||
|
Prepaid expenses
|
|
|
||||||
|
Total current assets
|
|
|
||||||
|
Equipment
|
|
|
||||||
|
Total assets
|
$
|
|
$
|
|
||||
|
LIABILITIES AND SHAREHOLDERS’ (DEFICIENCY)
|
||||||||
|
Current liabilities
|
||||||||
|
Accounts payable and accrued liabilities
|
$
|
|
$
|
|
||||
|
Mandatory convertible debentures
|
|
|
||||||
|
Convertible debentures
|
|
|
||||||
|
Derivative liabilities
|
|
|
||||||
|
Warrant liabilities
|
||||||||
|
Total current liabilities
|
|
|
||||||
|
Shareholders’ (deficiency)
|
||||||||
|
Common shares (
|
|
|
||||||
|
Additional paid in capital
|
|
|
||||||
|
Accumulated other comprehensive loss
|
|
|
||||||
|
Deficit
|
(
|
)
|
(
|
)
|
||||
|
Total shareholders’ (deficiency)
|
(
|
)
|
(
|
)
|
||||
|
Total liabilities and shareholders’ (deficiency)
|
$
|
|
$
|
|
||||
|
DevvStream Holding Inc.
|
|
CONDENSED CONSOLIDATED INTERIM STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
|
|
(Unaudited Expressed in United States dollars)
|
|
For the three months ended October 31,
|
2024
|
2023
|
||||||
|
Operating expenses
|
||||||||
|
Sales and marketing
|
$
|
|
$
|
|
||||
|
Depreciation
|
|
|
||||||
|
General and administrative
|
|
|
||||||
|
Professional fees
|
|
|
||||||
|
Salaries and wages
|
|
|
||||||
|
Total operating expenses
|
(
|
)
|
(
|
)
|
||||
|
Other income/(expenses)
|
||||||||
|
Foreign exchange gain (loss)
|
|
(
|
)
|
|||||
|
Interest (expense)
|
(
|
)
|
|
|||||
|
Accretion (expense)
|
(
|
)
|
|
|||||
|
Change in fair value of derivative liabilities
|
(
|
)
|
|
|||||
| Change in fair value of warrant liabilities |
( |
) | ||||||
|
Change in fair value of mandatory convertible debentures
|
|
|
||||||
|
(Loss) on settlement of accounts payable
|
(
|
)
|
||||||
|
Net loss
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
Other comprehensive loss
|
||||||||
|
Foreign currency translation
|
|
|
||||||
|
Net loss and comprehensive loss
|
(
|
)
|
(
|
)
|
||||
|
Weighted average number of shares – Basic and diluted
|
|
|
||||||
|
Loss per share – Basic and diluted
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
DevvStream Holdings Inc.
|
||||||||||||||
|
CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CHANGES IN SHAREHOLDERS’ (DEFICIENCY)
|
||||||||||||||
|
(Unaudited Expressed in United States dollars)
|
|
Number of
Subordinate
Voting Stock
|
Number of
Multiple Voting
Stock
|
Additional
Paid-in
Capital
|
Accumulated
Deficit
|
Accumulated
other
comprehensive
income (loss)
|
Total
shareholders’
equity
(deficiency)
|
|||||||||||||||||||
|
Balance, July 31, 2023
|
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
|||||||||||
|
Share based compensation – RSUs
|
-
|
-
|
|
|
|
|
||||||||||||||||||
|
Share based compensation – Options
|
-
|
-
|
|
|
|
|
||||||||||||||||||
|
Shares issued for warrant exercises
|
|
|
|
|
|
|
||||||||||||||||||
|
Foreign currency translation
|
- |
-
|
|
|
|
|||||||||||||||||||
|
Net loss
|
- | - |
(
|
)
|
(
|
)
|
||||||||||||||||||
|
Balance, October 31, 2023
|
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
|||||||||||
|
Balance, July 31, 2024
|
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
||||||||||||
|
Share based compensation - RSUs
|
-
|
-
|
|
|
|
|
||||||||||||||||||
|
Share based compensation - Options
|
-
|
-
|
|
|
|
|
||||||||||||||||||
| Warrants reclassified to liabilities on change in functional currency |
- | - | ( |
) | ( |
) | ||||||||||||||||||
|
Shares issued for warrant exercises
|
|
|
|
|
||||||||||||||||||||
|
Conversion of mandatory convertible debentures
|
|
|
|
|
||||||||||||||||||||
|
Shares for settlement of debt
|
|
|
|
|
||||||||||||||||||||
|
Foreign currency translation
|
-
|
-
|
|
|
|
|
||||||||||||||||||
|
Net loss
|
-
|
-
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||||
|
Balance, October 31, 2024
|
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
||||||||||||
|
DevvStream Holdings Inc.
|
|
CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CASH FLOWS
|
|
(Unaudited Expressed in United States dollars)
|
|
For the period ended October 31,
|
2024
|
2023
|
||||||
|
Operating activities
|
||||||||
|
Net loss for the period
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
Items not affecting cash:
|
||||||||
|
Depreciation
|
|
|
||||||
|
Share based compensation
|
|
|
||||||
|
Change in fair value of derivative liabilities
|
|
|
||||||
|
Change in fair value of mandatory convertible debentures
|
(
|
)
|
|
|||||
| Change in fair value of warrant liabilities |
||||||||
|
Loss on settlement of accounts payable
|
|
|||||||
|
Non-cash general and administrative
|
|
|||||||
|
Accrued interest
|
|
|
||||||
|
Accretion expense
|
|
|
||||||
|
Changes in non-cash working capital items:
|
||||||||
|
GST receivable
|
(
|
)
|
(
|
)
|
||||
|
Prepaid expenses
|
|
|
||||||
|
Accounts payable and accrued liabilities
|
|
|
||||||
|
Net cash used in operating activities
|
(
|
)
|
(
|
)
|
||||
|
Financing activities
|
||||||||
|
Proceeds from convertible debentures
|
|
|
||||||
|
Proceeds from warrant exercise
|
|
|
||||||
|
Proceeds from issuance of mandatory convertible debentures
|
|
|||||||
|
Net cash provided by financing activities
|
|
|
||||||
|
Effect of exchange rate changes on cash
|
|
(
|
)
|
|||||
|
Net (decrease) in cash
|
(
|
)
|
(
|
)
|
||||
|
Cash, Beginning
|
|
|
||||||
|
Cash, Ending
|
$
|
|
$
|
|
||||
|
Supplemental information:
|
||||||||
|
Taxes paid
|
$
|
|
$
|
|
||||
|
Interest paid
|
$
|
|
$
|
|
||||
| Fair value of warrants exercised |
$ |
$ |
||||||
| For the three months ended October 31, 2024 and 2023 |
|
1.
|
Nature of operations
|
|
2.
|
Basis of preparation
|
|
(a)
|
Statement of compliance
|
| For the three months ended October 31, 2024 and 2023 |
|
2.
|
Basis of preparation (continued)
|
|
(b)
|
Going concern
|
|
(c)
|
Basis of consolidation
|
|
Name of subsidiary
|
Place of incorporation
|
Ownership
|
|||
|
Devvstream, Inc. (“DESG”)
|
Delaware, USA
|
|
%
|
||
|
DevvESG Streaming Finco Ltd (“Finco”)
|
British Columbia, Canada
|
|
%
|
||
|
(d)
|
Variable interest entities (“VIE”)
|
| For the three months ended October 31, 2024 and 2023 |
|
2.
|
Basis of preparation (continued)
|
|
(e)
|
Functional and presentation currencies
|
| (f) |
Use of estimates and judgments
|
| (g) |
Emerging growth company
|
| For the three months ended October 31, 2024 and 2023 |
|
3.
|
Significant accounting policies
|
| 4. |
Accounts payable and accrued liabilities
|
|
October 31, 2024
|
July 31, 2024
|
|||||||
|
Accounts payable
|
$
|
|
$
|
|
||||
|
Accrued liabilities
|
|
|
||||||
|
Income taxes payable
|
|
|
||||||
|
$
|
|
$
|
|
|||||
| 5. |
Convertible debentures
|
| • |
At a conversion price equal to the greater of (a) $
|
| • |
If the Company completes the De-SPAC transaction, and the convertible notes are not converted into shares, the maturity date will accelerate and the principal plus interest will become repayable within
|
| • |
At a conversion price equal to the greater of (a) the
|
| • |
Each warrant will carry the right to purchase a share with an exercise price equal to the greater of (a) a
|
| For the three months ended October 31, 2024 and 2023 |
|
5.
|
Convertible debentures (continued)
|
| • |
At a conversion price equal to the greater of (a) a
|
| • |
The shares are thereafter exchanged for common shares of Focus Impact at the Common Conversion Ratio.
|
| • |
If the Company completes the De-SPAC transaction, and the convertible notes are not converted into shares, the maturity date will accelerate and the principal plus interest will become repayable within
|
| • |
At a conversion price equal to the greater of (a) a
|
| • |
Each warrant will carry the right to purchase a share with an exercise price equal to the greater of (a) a
|
| • |
The warrants will expire
|
| For the three months ended October 31, 2024 and 2023 |
|
5.
|
Convertible debentures (continued)
|
| • |
At a conversion price equal to the greater of (a) the price that is a
|
| • |
If the Company completes the De-SPAC transaction, and the convertible notes are not converted into shares, the maturity date will accelerate and the principal plus interest will become repayable within
|
| • |
At a conversion price equal to the greater of (a) the price that is a
|
| • |
Each warrant will carry the right to purchase a share with an exercise price equal to the greater of (a) a
|
| For the three months ended October 31, 2024 and 2023 |
|
5.
|
Convertible debentures (continued)
|
|
Balance as at August 1, 2023
|
$
|
|
||
|
Issued
|
|
|||
|
Fair value of embedded derivative
|
(
|
)
|
||
|
Transaction costs
|
(
|
)
|
||
|
Accretion
|
|
|||
|
Interest
|
|
|||
|
Balance as at July 31, 2024
|
$
|
|
||
|
Issued (Focus Impact Partners Convertible Debt)
|
|
|||
|
Fair value of embedded derivative
|
(
|
)
|
||
|
Accretion
|
|
|||
|
Interest
|
|
|||
|
Balance as at October 31, 2024
|
$
|
|
|
Balance as at August 1, 2023
|
$
|
|
||
|
Derivative liability component
|
|
|||
|
Change in fair value of derivative liabilities
|
|
|||
|
Balance as at July 31, 2024
|
$
|
|
||
|
Derivative liability component
|
|
|||
|
Change in fair value of derivative liabilities
|
|
|||
|
Balance as at October 31, 2024
|
$
|
|
|
At initial
measurement (for
the year ended July
31, 2024)
|
As at
July 31, 2024
|
At initial
measurement (for
the period ended
October 31, 2024)
|
As at
October 31, 2024
|
|||||||||||||
|
Probability of De-SPAC Transaction closing
|
|
%
|
|
%
|
|
%
|
|
%
|
||||||||
|
Risk-free interest rate
|
|
%
|
|
%
|
|
%
|
|
%
|
||||||||
|
Expected term (years)
|
|
|
|
|
||||||||||||
|
Expected annual volatility for the Company
|
|
%
|
|
%
|
|
%
|
|
%
|
||||||||
|
Expected annual volatility for Focus Impact
|
|
%
|
|
%
|
|
%
|
|
%
|
||||||||
|
Common conversion ratio
|
|
|
|
|
||||||||||||
|
Foreign exchange rate
|
|
|
|
|
||||||||||||
| For the three months ended October 31, 2024 and 2023 |
|
6.
|
Mandatory convertible debentures
|
| • |
At a conversion price equal to the greater of (a) $
|
| • |
The shares are thereafter exchanged for common shares of Focus Impact at the Common Conversion Ratio.
|
| • |
At a conversion price equal to the greater of (a) the
|
| • |
Each warrant will carry the right to purchase a share with an exercise price equal to the greater of (a) a
|
|
Balance as at August 1, 2023
|
$
|
|
||
|
Issued
|
|
|||
|
Change in fair value of mandatory convertible debentures
|
|
|||
|
Balance as at July 31, 2024
|
$
|
|
||
|
Change in fair value of mandatory convertible debentures
|
(
|
)
|
||
|
Conversion of debentures
|
(
|
)
|
||
|
Balance as at October 31, 2024
|
$
|
|
|
As at July 31, 2024
|
||||
|
Probability of De-SPAC Transaction closing by maturity date
|
% | |||
|
Risk-free interest rate
|
|
%
|
||
|
Expected term (years)
|
|
|||
|
Expected annual volatility for the Company
|
|
%
|
||
|
Expected annual volatility for Focus Impact
|
|
%
|
||
|
Common conversion ratio
|
|
|||
|
Foreign exchange rate
|
|
|||
| For the three months ended October 31, 2024 and 2023 |
|
Balance as at July 31, 2024
|
$
|
|
||
|
Warrant fair value upon change in functional currency (Note 2)
|
|
|||
|
Warrants to be issued (mandatory convertible debentures)
|
|
|||
|
Change in fair value of warrant liabilities (exercised warrants)
|
|
|||
|
Fair value of warrants exercised
|
(
|
)
|
||
|
Change in fair value of warrant liabilities
|
|
|||
|
Balance as at October 31, 2024
|
$
|
|
|
Number of warrants outstanding
|
Exercise price
|
Expiry date
|
|
|
CAD$
|
|
|
|
CAD$
|
|
|
|
CAD$
|
|
|
|
|
8.
|
Share capital
|
| (a) |
Authorized
|
| (b) |
Shares issued
|
|
(c)
|
Share purchase warrants
|
|
Number of
warrants
|
Weighted
Average Exercise
price
|
Remaining
life (Years)
|
|||||||
|
Balance, July 31, 2023
|
|
CAD$
|
|
||||||
|
Exercised
|
(
|
)
|
CAD$
|
-
|
|||||
|
Balance, July 31, 2024
|
|
CAD$
|
|
||||||
|
Exercised
|
(
|
)
|
CAD$
|
-
|
|||||
|
Balance, October 31, 2024
|
|
CAD$
|
|
||||||
|
Number of warrants outstanding
|
Exercise price
|
Expiry date
|
|||
|
|
CAD$
|
|
|||
|
|
CAD$
|
|
|||
|
|
CAD$
|
|
|||
|
|
| For the three months ended October 31, 2024 and 2023 |
|
8.
|
Share capital (continued)
|
| (d) |
Options
|
|
Number of
options
|
Weighted average
exercise price
|
||||||
|
Outstanding, October 31, 2024 and July 31, 2024
|
|
CAD$
|
|||||
|
Exercisable, July 31, 2024
|
|
CAD$
|
|||||
|
Exercisable, October 31, 2024
|
|
CAD$
|
|||||
|
Number of options
outstanding
|
Exercise
price
|
Expiry date
|
Number of
options
exercisable
|
||||||||
|
|
CAD$
|
|
|
||||||||
|
|
CAD$
|
|
|
||||||||
|
|
CAD$
|
|
|
||||||||
|
|
CAD$
|
|
|
||||||||
|
|
CAD$
|
|
|
||||||||
|
|
CAD$
|
|
|
||||||||
|
|
CAD$
|
|
|
||||||||
|
|
CAD$
|
|
|
||||||||
|
|
CAD$
|
|
|
||||||||
|
|
|
||||||||||
|
(e)
|
Restricted stock units (“RSUs”)
|
|
Number of RSU’s
|
||||
|
Outstanding, July 31, 2023
|
|
|||
|
Granted
|
|
|||
|
Outstanding, July 31, 2024
|
|
|||
|
Forfeited
|
(
|
)
|
||
|
Outstanding, October 31, 2024
|
|
|||
| For the three months ended October 31, 2024 and 2023 |
| 8. |
Share capital (continued)
|
| (e) |
RSU’s (continued)
|
|
Number of RSUs
outstanding
|
Grant date
|
Number of RSUs
Vested
|
||||||
|
|
November 30, 2021
|
|
||||||
|
|
December 24, 2021
|
|
||||||
|
|
March 1, 2022
|
|
||||||
|
|
March 14, 2022
|
|
||||||
|
|
July 30, 2024
|
|
||||||
|
|
|
|||||||
| 9. |
Related party transactions and balances
|
| For the three months ended October 31, 2024 and 2023 |
|
10.
|
Financial instruments
|
| (a) |
Credit risk
|
| (b) |
Liquidity risk
|
| (c) |
Market risk
|
| For the three months ended October 31, 2024 and 2023 |
| 11. |
Segmented information
|
| 12. |
Commitments and contingencies
|
| • |
On September 12, 2023, the Company amended their existing strategic partnership agreement with Devvio, a related party. The Company has committed to making specific payments to Devvio. They will
provide a minimum advance of $
|
| • |
On February 16, 2024, the Company entered into a licensing agreement with Greenlines Technology Inc. for the use of certain technologies. The Company has agreed to pay $
|
| • |
From time to time, the Company may be involved in litigation relating to claims arising out of operations in the normal course of business. At October 31, 2024, there were
|
| For the three months ended October 31, 2024 and 2023 |
| 13. |
Subsequent events
|
|
•
|
|
|
•
|
|
|
•
|
|
|
•
|
|
| For the three months ended October 31, 2024 and 2023 |
| For the three months ended October 31, 2024 and 2023 |